Iron chelation by oral deferoxamine treatment decreased brain iron and iron signaling proteins

No abstract is available for this paper.

• Publication year

  2024

• Venue

  bioRxiv

• Publication date

  2024-08-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1101/2024.08.14.607970PMID 39211245PMCID PMC11361199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Iron‐associated lipid peroxidation in Alzheimer's disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice

  2023influential reference
• Iron response elements (IREs)-mRNA of Alzheimer's amyloid precursor protein binding to iron regulatory protein (IRP1): a combined molecular docking and spectroscopic approach

  2023cited by this paper
• An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells

  2022cited by this paper
• Enhanced defense against ferroptosis ameliorates cognitive impairment and reduces neurodegeneration in 5xFAD mice.

  2022cited by this paper
• Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway

  2022cited by this paper
• Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury

  2021cited by this paper
• Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance

  2021cited by this paper
• Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice.

  2021influential reference
• APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β

  2021cited by this paper
• Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.

  2020cited by this paper
• Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer’s disease: Evidence of ferroptosis

  2020cited by this paper
• A local difference in blood–brain barrier permeability in the caudate putamen and thalamus of a rat brain induced by focused ultrasound

  2020cited by this paper
• Ferroptosis: molecular mechanisms and health implications

  2020cited by this paper
• Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease Using 3-T MRI.

  2020cited by this paper
• Iron Dyshomeostasis Induces Binding of APP to BACE1 for Amyloid Pathology, and Impairs APP/Fpn1 Complex in Microglia: Implication in Pathogenesis of Cerebral Microbleeds

  2019cited by this paper
• Renal clearable nanochelators for iron overload therapy

  2019cited by this paper
• Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis

  2018cited by this paper
• Brain Endothelial Erythrophagocytosis and Hemoglobin Transmigration Across Brain Endothelium: Implications for Pathogenesis of Cerebral Microbleeds

  2018cited by this paper
• 4‐Hydroxynonenal (HNE) modified proteins in metabolic diseases

  2017cited by this paper
• Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice.

  2017cited by this paper
• Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling.

  2017cited by this paper
• Iron deficiency induces autophagy and activates Nrf2 signal through modulating p62/SQSTM.

  2017cited by this paper
• Iron Regulates Apolipoprotein E Expression and Secretion in Neurons and Astrocytes

  2016cited by this paper
• Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment

  2016cited by this paper
• ' s response to reviews Title : ROCKETSHIP : a flexible and modular software tool for the planning , processing and analysis of dynamic MRI studies

  2015cited by this paper
• Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation.

  2015cited by this paper
• Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy

  2014cited by this paper
• Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds

  2014cited by this paper
• Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

  2012cited by this paper
• Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability

  2012cited by this paper
• Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

  2009cited by this paper
• Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by curcumin.

  2008cited by this paper
• Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.

  2004influential reference
• Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

  2002cited by this paper
• Lipid peroxidation in aging brain and Alzheimer's disease.

  2002cited by this paper
• An Iron-responsive Element Type II in the 5′-Untranslated Region of the Alzheimer's Amyloid Precursor Protein Transcript*

  2002cited by this paper
• Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm

  2001cited by this paper
• Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique.

  2000cited by this paper
• Multivalent DNA Binding Complex Generated by Small Maf and Bach1 as a Possible Biochemical Basis for β-Globin Locus Control Region Complex*

  1998cited by this paper
• DEFEROXAMINE STARCH CONJUGATE PROVIDES PARTIAL PROTECTION FROM HYPOXIC-ISCHEMIC BRAIN INJURY IN NEONATAL RATS † 1749

  1997cited by this paper
• COPPER(II), NICKEL(II), ZINC(II), AND MOLYBDENUM(VI) COMPLEXES OF DESFERRIOXAMINE B IN AQUEOUS SOLUTION

  1997cited by this paper
• Iron-chelating therapy and the treatment of thalassemia.

  1997cited by this paper
• Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.

  1996cited by this paper
• Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism.

  1995cited by this paper
• Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs.

  1995cited by this paper
• Iron (III) can be transferred between ferritin molecules

  1991cited by this paper
• Intramuscular desferrioxamine in patients with Alzheimer's disease.

  1991cited by this paper
• Enzymatic reduction of phospholipid and cholesterol hydroperoxides in artificial bilayers and lipoproteins.

  1990cited by this paper
• Deferoxamine for aluminum toxicity in dialysis patients.

  1990cited by this paper
• The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes.

  1985influential reference
• The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism

  1964cited by this paper

• Reexamining the Role of Amyloid β Clearance from the Brain: Exporting Labile Iron from the Interstitial Fluid Performs a Protective Function

  2026cites this paper
• Down syndrome with Alzheimer’s disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis

  2025cites this paper
• The blood–brain barrier as a treatment target for neurodegenerative disorders

  2025cites this paper
• Regulation of iron metabolism in ferroptosis: From mechanism research to clinical translation

  2025cites this paper
• Cerebral microbleeds and renal dysfunction: Degenerative neurobiological shared mechanisms within intracerebral hemorrhage.

  2025cites this paper
• Iron‐associated lipid peroxidation in Alzheimer's disease is increased in lipid rafts with decreased ferroptosis suppressors, tested by chelation in mice

  2023cites this paper